Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies.


Journal

Advances in anatomic pathology
ISSN: 1533-4031
Titre abrégé: Adv Anat Pathol
Pays: United States
ID NLM: 9435676

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 30 4 2019
medline: 27 12 2019
entrez: 30 4 2019
Statut: ppublish

Résumé

Well-differentiated neuroendocrine carcinoma (also known as "carcinoid") of the larynx is an exceedingly rare tumor that has an epithelial origin. These tumors are malignant and have a low, but definite, risk of metastasis. Although it can be challenging, this tumor should be differentiated from moderately differentiated neuroendocrine carcinoma (also known as "atypical carcinoid"). The clinical and pathologic features of this tumor, as well as treatment and prognosis, are reviewed in detail.

Identifiants

pubmed: 31033507
doi: 10.1097/PAP.0000000000000236
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

246-250

Auteurs

Jennifer L Hunt (JL)

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR.

Leon Barnes (L)

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Asterios Triantafyllou (A)

Department of Pathology, Liverpool Clinical Laboratories, School of Dentistry, University of Liverpool, Liverpool, UK.

Douglas R Gnepp (DR)

Warren Alpert Medical School at Brown University, Providence, RI.

Kenneth O Devaney (KO)

Department of Pathology, Allegiance Health, Jackson, MI.

Göran Stenman (G)

Department of Pathology and Genetics, Sahlgrenska Cancer Center, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

Gyorgy B Halmos (GB)

Department of Otorhinolaryngology-Head and Neck Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Justin A Bishop (JA)

Department of Pathology, UT Southwestern Medical Center, Dallas, TX.

Alena Skálová (A)

Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic.

Stefan M Willems (SM)

Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

Henrik Hellquist (H)

CBMR, Centre for Biomedical Research.
Epigenetics and Human Disease Laboratory, Department of Biomedical Sciences and Medicine.
Algarve Biomedical Centre, Campus Gambelas, University of Algarve, Faro, Portugal.

Alessandra Rinaldo (A)

University of Udine School of Medicine, Udine.

Alfio Ferlito (A)

Coordinator of the International Head and Neck Scientific Group, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH